Israel Englander Medpace Holdings, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 109,803 shares of MEDP stock, worth $39.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

109,803

Previous 23,500 367.25%

Holding current value

$39.3 Million

Previous $9.5 Million 376.17%

% of portfolio

0.02%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $9.53 Million - $10.9 Million	-25,629 Reduced 18.92%	109,803 $45.2 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $19 Million - $27.6 Million	66,736 Added 97.15%	135,432 $54.7 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $81.9 Million - $113 Million	-360,081 Reduced 83.98%	68,696 $21.1 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $3.98 Million - $5.1 Million	21,234 Added 5.21%	428,777 $103 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $7.56 Million - $10.4 Million	-43,395 Reduced 9.62%	407,543 $76.6 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $37.2 Million - $55.1 Million	243,001 Added 116.86%	450,938 $95.8 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $1.72 Million - $2.16 Million	11,850 Added 6.04%	207,937 $32.7 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $3.2 Million - $4.13 Million	24,566 Added 14.32%	196,087 $29.3 Million
Q1 2022 May 16, 2022	BUY	$138.87 - $214.31 $16.9 Million - $26.1 Million	121,787 Added 244.88%	171,521 $28.1 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $653,660 - $815,198	-3,577 Reduced 6.71%	49,734 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $7.14 Million - $8.32 Million	41,979 Added 370.45%	53,311 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $1.8 Million - $2.2 Million	11,332 New	11,332 $2 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $575,211 - $733,108	-4,357 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $10.2 Million - $14 Million	-93,550 Reduced 95.55%	4,357 $606,000
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $6.89 Million - $9.68 Million	74,082 Added 310.94%	97,907 $10.9 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $1.62 Million - $2.28 Million	23,825 New	23,825 $2.22 Million
Q1 2020 May 14, 2020	SELL	$61.71 - $101.95 $186,240 - $307,685	-3,018 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $5.91 Million - $7.14 Million	-84,358 Reduced 96.55%	3,018 $254,000
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $49.3 Million - $67.9 Million	-790,448 Reduced 90.05%	87,376 $7.34 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $45.3 Million - $55.3 Million	844,891 Added 2565.48%	877,824 $2.77 Million
Q1 2019 May 14, 2019	SELL	$49.38 - $70.58 $11.7 Million - $16.7 Million	-236,693 Reduced 87.79%	32,933 $1.94 Million
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $5.12 Million - $6.98 Million	-109,063 Reduced 28.8%	269,626 $14.3 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $12.5 Million - $18.5 Million	290,038 Added 327.17%	378,689 $22.7 Million
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $3.02 Million - $4.03 Million	88,651 New	88,651 $3.81 Million
Q1 2018 May 15, 2018	SELL	$32.03 - $39.05 $443,743 - $540,998	-13,854 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$32.46 - $38.31 $2.65 Million - $3.13 Million	-81,772 Reduced 85.51%	13,854 $502,000
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $2.62 Million - $3.17 Million	95,626	95,626 $3.05 Million

Others Institutions Holding MEDP

# of Institutions

632

Shares Held

25.1M

Call Options Held

38.7K

Put Options Held

64.7K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $11.1B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account